Test Price
2,800 AED✅ Home Collection Available
HARS2 Gene Perrault Syndrome Type 2 NGS Genetic Test in UAE – DNA Labs UAE
Clinical Executive Summary & Core Metrics
Test Overview & Methodology
The HARS2 Gene NGS Test analyzes the HARS2 gene using next-generation sequencing (NGS) to detect pathogenic mutations associated with Perrault Syndrome Type 2, a rare autosomal recessive disorder characterized by sensorineural hearing loss and ovarian dysfunction. This highly accurate molecular diagnostic assay provides definitive genotyping to guide clinical management, genetic counseling, and family planning.
| Parameter | Our Test (NGS – Next-Generation Sequencing) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision / Method | Full gene coverage, detects known and novel variants; high-throughput NGS | Limited to pre‑defined mutations; lower discovery power |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Diagnostic Sensitivity | > 99.9% (ISO 9001:2015 certified) | ~95% for targeted regions |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I emphasize that genetic testing for Perrault Syndrome Type 2 requires comprehensive pre- and post-test counseling. The HARS2 gene analysis via NGS offers high diagnostic yield, but results must be interpreted strictly within the clinical context. A negative result does not exclude a genetic etiology, and a positive result necessitates informed discussion regarding inheritance patterns and family screening."
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Medication & Clinical Advisory
⚠️ Important Advisory: Do not discontinue prescribed medications or therapies without consulting your physician. Genetic test results are intended to support clinical decision-making and should not replace your current treatment plan without a multidisciplinary review.
Exclusion Criteria & Emergency Red Flags
- Active acute infection or febrile illness – consider postponing non-urgent genetic testing.
- Inability to provide informed consent (minors require legal guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- If you experience sudden severe hearing loss, acute abdominal pain, or seizures, seek emergency care immediately – this test is not a substitute for urgent medical evaluation.
- This test is not designed for prenatal diagnosis without prior genetic counselling.
Patient FAQ & Clinical Guidance
1. What is the HARS2 Gene Perrault Syndrome Type 2 NGS Test and why is it performed?
This next-generation sequencing test examines HARS2 gene mutations causing Perrault Syndrome Type 2, a condition involving hearing loss and ovarian dysfunction. It is used for accurate diagnosis, genetic counseling, and family planning.
2. How is the sample collected and what is the turnaround time?
A simple blood sample, extracted DNA, or a single drop on an FTA card is collected via our VIP Mobile Phlebotomy service at your home. Results are available within 3 to 4 weeks.
3. Is this genetic test covered by insurance in the UAE?
We offer direct billing verification via WhatsApp at +971 54 548 8731 to check your insurance coverage for genetic testing and assist with claim submissions.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Federal Decree-Law No. 4 of 2016 on Medical Liability.
All genetic data remains strictly confidential. Results are securely released only to the authorized physician and the patient. Laboratory operations are certified to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | HARS2 Gene NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | H90.5, Q87.8 |
| LOINC Code | 91703-3 |
| DHA Facility License & Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians